APM in the Evoke SCS System to Program Patients With Chronic Pain of the Trunk and/or Limbs
CompletedNot applicableNCT06057480
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Study to evaluate the use of the Assisted Programming Module (APM) in the Evoke Spinal Cord Stimulation (SCS) System to program patients with chronic pain of the trunk and/or limbs.
Study details
- Official title
- A Prospective, Multicenter, Single-arm Study Examining the Assisted Programming Module (APM) in the Evoke Spinal Cord Stimulation (SCS) System to Program Patients With Chronic Pain of the Trunk and/or Limbs
- Conditions
- Interventions
- Device: Evoke Spinal Cord Stimulation System
- Sponsor
- Saluda Medical Pty Ltd
- Start date
- 2023-09-26
- Primary completion
- 2024-12-19
- Sex
- All
- Age range
- from 18 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 4
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Subject has or is planning to undergo a temporary trial with Evoke System within the FDA approved indication. * Subject is willing and capable of giving informed consent and able to comply with study-related requirements. Exclusion Criteria: * There are no exclusion criteria.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06057480